Patents

US 12679860 B2: C-terminal HSP90 inhibitors

Granted
2026-07-14
Filed
2024-05-17 application 18667496
Type
Utility · 20 claims
Elsewhere
Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗

Abstract

Hsp90 C-terminal inhibitors and pharmaceutical compositions containing such compounds are provided. The compounds of the disclosure are useful for the treatment and/or prevention of neurodegenerative disorders such as diabetic peripheral neuropathy.

Source: PTBLXML, file of 2026-07-14 (ipgb20260714.xml).

Assignees

AssigneeTypePlaceAlso on furp.orgSource
UNIVERSITY OF KANSAS 437 patentsUS company or organizationLawrence, KSUniversity of Kansas College or university EXACT high confidence: identical full name and state
UNIVERSITY OF KANSAS Federal lobbying client EXACT high confidence: identical full name and state
PTBLXML, file of 2026-07-14

Inventors

InventorPlacePatentsPerson pageSource
Brian S.J. BlaggLawrence, KS33PTBLXML, file of 2026-07-14
Bhaskar Reddy KusumaLake Ronkonkoma, NY8PTBLXML, file of 2026-07-14
Teather SundstromEckelson, ND7PTBLXML, file of 2026-07-14

CPC categories

SubclassCategoryFirst groupSource
C07HSugars; derivatives thereof; nucleosides; nucleotides; nucleic acidsC07H15/207PTBLXML, file of 2026-07-14
C07CAcyclic or carbocyclic compoundsC07C211/17PTBLXML, file of 2026-07-14

Cooperative Patent Classification, as currently assigned (one row per subclass).

Assignments and security interests

No recorded assignments or security interests on file for this patent.

USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.